Cabergoline and Bone pain aggravated - a phase IV clinical study of FDA data

Summary:

Bone pain aggravated is found among people who take Cabergoline, especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Cabergoline and have Bone pain aggravated. It is created by eHealthMe based on reports of 5,170 people who have side effects when taking Cabergoline from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 04, 2022

5,170 people reported to have side effects when taking Cabergoline.
Among them, 61 people (1.18%) have Bone pain aggravated.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 5,453 Cabergoline users for its effectiveness, alternative drugs and more.

What is Bone pain aggravated?

Bone pain aggravated is found to be associated with 896 drugs and 298 conditions by eHealthMe.

Number of Cabergoline and Bone pain aggravated reports submitted per year:

Could Cabergoline cause Bone pain aggravated?

Time on Cabergoline when people have Bone pain aggravated *:

Gender of people who have Bone pain aggravated when taking Cabergoline *:

female: 84.78 %
male: 15.22 %

Age of people who have Bone pain aggravated when taking Cabergoline *:

Common drugs people take besides Cabergoline *:

Common side effects people have besides Bone pain aggravated *:

Headache (pain in head): 44 people, 72.13%
Pain: 36 people, 59.02%
Fatigue (feeling of tiredness): 35 people, 57.38%
Dizziness: 29 people, 47.54%
Malaise (a feeling of general discomfort or uneasiness): 28 people, 45.90%
Joint Pain: 25 people, 40.98%
Pain In Extremity: 25 people, 40.98%
Rashes (redness): 24 people, 39.34%
Fainting (loss of consciousness and postural tone): 22 people, 36.07%
Weakness: 21 people, 34.43%

Common conditions people have *:

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 35 people, 57.38%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 14 people, 22.95%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 11 people, 18.03%
Bone Atrophy (decrease in bone mass): 11 people, 18.03%
Diabetes: 8 people, 13.11%
Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 9.84%
Pain: 6 people, 9.84%
Catarrh (inflammation of mucous membranes, especially of the nose and throat): 5 people, 8.20%
Depression: 5 people, 8.20%
Sinusitis (inflammation of sinus): 5 people, 8.20%

* Approximation only. Some reports may have incomplete information.

Do you take Cabergoline and have Bone pain aggravated?

Check whether Bone pain aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .

Related studies

How severe was Bone pain aggravated and when was it recovered:

Bone pain aggravated in Cabergoline

Expand to all the drugs that have ingredients of cabergoline:

Bone pain aggravated and drugs with ingredients of cabergoline

Alternative drugs to, pros and cons of Cabergoline:

Cabergoline (5,453 reports)

Common Cabergoline side effects:

Headache (pain in head): 451 reports
Fatigue (feeling of tiredness): 411 reports
Drug ineffective: 348 reports
Pain: 331 reports
High blood pressure: 325 reports
Dizziness: 323 reports
Malaise (a feeling of general discomfort or uneasiness): 279 reports
Weakness: 254 reports

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bone pain aggravated treatments and more:

Bone pain aggravated (48 reports)

COVID vaccines that are related to Bone pain aggravated:

Common drugs associated with Bone pain aggravated:

All the drugs that are associated with Bone pain aggravated:

Bone pain aggravated (896 drugs)

Common conditions associated with Bone pain aggravated:

All the conditions that are associated with Bone pain aggravated:

Bone pain aggravated (298 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabergoline (the active ingredients of Cabergoline) and Cabergoline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.